Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

· WestVac Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell), covering 2024-04-23 to 2024-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) [Phase 3]

See pricing